JACOB LEONARD S 4
4 · ANTARES PHARMA, INC. · Filed Nov 4, 2019
Insider Transaction Report
Form 4
JACOB LEONARD S
Director
Transactions
- Exercise/Conversion
Common Stock
2019-10-31$1.10/sh+20,000$22,000→ 297,563 total - Exercise/Conversion
Stock Option (right to buy)
2019-10-31−20,000→ 0 totalExercise: $1.10Exp: 2019-11-12→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The options vested and became exercisable in four equal quarterly installments following the grant date of November 12, 2009.